Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

CHNA vs. IYH: which is better?

Bottom line

CHNA vs IYH: the short answer

CHNA (Loncar China BioPharma ETF) and IYH (iShares U.S. Healthcare ETF) are both etfs.

Updated Nov 19, 2026

CHNA vs IYH side by side

CHNAIYH
TypeETFETF
Fund familyGrayscaleiShares
CategoryHealth Care SectorHealth Care Sector
Expense ratio—0.37%
Annual cost per $10k—$37
10-yr cost on $10k (prospectus)—$468
Max front loadNoneNone
12b-1 fee—0%
1-yr return—+13.1%
5-yr return (annualized)—+7.0%
10-yr return (annualized)—+9.4%
Best quarter—+15.3%
Worst quarter—−12.7%
Net assets (fund)—$3.6B
Number of holdings—103
Portfolio turnover—3%
Returns as of—Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

CHNA and IYH share none of their top holdings.

CHNA top 10

    IYH top 10

    1. Eli Lilly And Company — 15.11%
    2. Johnson & Johnson — 10.17%
    3. Abbvie Inc. — 7.32%
    4. Unitedhealth Group Incorporated — 6.16%
    5. Merck & Co., Inc. — 5.31%
    6. Thermo Fisher Scientific Incorporated — 3.52%
    7. Amgen Inc. — 3.42%
    8. Abbott Laboratories — 3.02%
    9. Gilead Sciences, Inc. — 2.66%
    10. Pfizer Inc. — 2.35%

    FAQ

    What is the difference between CHNA and IYH?
    CHNA (Loncar China BioPharma ETF) and IYH (iShares U.S. Healthcare ETF) are both etfs.
    Should I own both CHNA and IYH?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.